Spotlight On... WuXi partners up for genomics in China; Medidata stumbles in wire fraud case; and more...

Chinese CRO WuXi PharmaTech has teamed up with IT firm Huawei to develop a cloud-based data management platform to support the country's precision medicine initiative. The deal, through WuXi's NextCODE business, will match the CRO's expertise in genomics with Huawei's experience in building digital infrastructure, the companies said. More

> Clinical trial tech firms PointCross Life Sciences and Xybion are teaming up to market regulatory services to drugmakers ahead of a big shift in FDA rules. News

> A federal judge has refused to rule on a case stemming from the $4.8 million wire transfer fraud that was inflicted on Medidata ($MDSO) in 2014. Story

Suggested Articles

CTI Clinical Trial and Consulting Services is buying up fellow CRO Clinart to deepen its reach in the Middle Eastern and Northern African regions.

Viva Biotech is putting down $80 million to buy preclinical contract research organization SYNthesis and boost its outsourcing business.

Popular research network provider TriNetX has seen major interest from The Carlyle Group as it buys up a majority stake in the company.